Font Size: a A A
Keyword [HER2-positive]
Result: 1 - 20 | Page: 1 of 6
1. The Molecular Mechanism And RNAi Research About HER2 Positive Metastatic Gastric Cancer
2. Gene Construction, Expression, Purification And Targeted Killing Of Immunoproapoptotic Molecule E23sFv-TD-tBID Against HER2 Positive Carcinoma
3. The Mechanism Of Apoptosis Induced By Lapatinib In Her2 Positive Breast Cancer Cells And Synergistic Effective Between ABT-737 And Lapatinib
4. Gene Construction, Expression And Antitumor Effect Of Recombinant Immuno-tBid Molecules With Different Translocation Peptides On HER2 Positive Carcinoma
5. Contrastive Analysis Of Clinicopathologic Features And Prognosis Between Triple Negative Breast Cancer And HR Negative/HER2 Positive Breast Cancer
6. Expressions Of TopoⅡa Protein And Multivariate Analysis Of Survival Rates For HER2 Positive Breast Carcinoma
7. Novel Role Of MiR-375in Trastuzumab-resistance And Metastasis Of HER2-positive Breast Cancer
8. Study On AG490-enhanced Trastuzumab Sensitivity In HER2-positive Breast Cancer Cells
9. Study On The Role Of PRAS40 Phosphorylation At Thr246 In The Development Of Trastuzumab Resistance In HER2-positive Breast Cancer
10. Clinical Significance Of Circulating Tumor DNA Detection In HER2 Positive Advanced Breast Cancer Patients Treated With Target Therapy
11. A Research On Drug-resistant Mutations In HER2-positive Breast Cancer Based On Circulating Tumor DNA And CRISPR/cas9 Technique
12. Studies On Prognostic Prediction In HER2 Positive Breast Cancer And Treatment In Triple Negative Breast Cancer
13. MicroRNA-608Impacts Susceptibility And Progress Of HER2-positive Breast Cancer
14. Significance And Clinical And Pathological Features Of Akt2and HER2Protein Expression In Gastric Cancer
15. FW-04-806, A Macrolide Dilactone Compound, Shows Potent Efficacy Against HER2-positive Gastric Cancer Cell Lines
16. The Optimization Of Maintenance Treatment And A Exploratory Research Of HER2 Positive Metastatic Breast Cancer With Detection By CtDNA
17. Mechanism And Functional Research Of Autophagy Promoting Lapatinib Resistance Of HER2-Positive Breast Cancer Cells
18. Experimental Animal Study Of DCIK-Her2 Cell Anti-tumor Effect In Her2 Positive Breast Cancer
19. Research On The Paclitaxel/Lapatinib-loaded PEG-PLA Micelles For The Treatment Of HER2 Positive Breast Cancers
20. Ⅰ-Ⅱ Phase HER2 Positive Breast Cancer Neoadjuvant Therapy Efficacy And The Related Clinical Pathologic Factors Of Prospective Studies
  <<First  <Prev  Next>  Last>>  Jump to